You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
|
---|---|
Published in |
Journal of Pharmaceutical Policy and Practice, March 2021
|
DOI | 10.1186/s40545-021-00311-0 |
Pubmed ID | |
Authors |
Virginia Ronco, Myriam Dilecce, Elena Lanati, Pier Luigi Canonico, Claudio Jommi |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 103 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 19 | 18% |
Student > Master | 14 | 14% |
Researcher | 7 | 7% |
Student > Bachelor | 6 | 6% |
Other | 6 | 6% |
Other | 4 | 4% |
Unknown | 47 | 46% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 11% |
Medicine and Dentistry | 8 | 8% |
Biochemistry, Genetics and Molecular Biology | 7 | 7% |
Nursing and Health Professions | 6 | 6% |
Social Sciences | 5 | 5% |
Other | 16 | 16% |
Unknown | 50 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2022.
All research outputs
#6,949,499
of 22,788,370 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#165
of 405 outputs
Outputs of similar age
#156,169
of 423,801 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#8
of 22 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 405 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,801 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.